These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 8498304

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Management of patients with life-threatening sustained ventricular tachyarrhythmias--the role of guided antiarrhythmic drug therapy.
    Steinbeck G, Greene HL.
    Prog Cardiovasc Dis; 1996; 38(6):419-28. PubMed ID: 8638023
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS, Fineberg N, Heger JJ, Miles WM, Kammerling JM, Chang MS, Zipes DP, Prystowsky EN.
    Am J Cardiol; 1988 May 01; 61(13):1024-30. PubMed ID: 3364357
    [Abstract] [Full Text] [Related]

  • 7. Potential proarrhythmic effect of biventricular pacing: fact or myth?
    Shukla G, Chaudhry GM, Orlov M, Hoffmeister P, Haffajee C.
    Heart Rhythm; 2005 Sep 01; 2(9):951-6. PubMed ID: 16171749
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol.
    Leite LR, Fenelon G, Simoes A, Silva GG, Friedman PA, de Paola AA.
    J Cardiovasc Electrophysiol; 2003 Jun 01; 14(6):567-73. PubMed ID: 12875414
    [Abstract] [Full Text] [Related]

  • 10. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F, Rolli A, Carboni A, Finardi A, Aurier E, Favaro L, Contini S, Gherli T, Caponi D, Maranga SS, Lepera G, Bartoletti A.
    G Ital Cardiol; 1999 Oct 01; 29(10):1142-56. PubMed ID: 10546124
    [Abstract] [Full Text] [Related]

  • 11. Prospective, randomized comparison of conventional and high dose loading regimens of amiodarone in the treatment of ventricular tachycardia.
    Kalbfleisch SJ, Williamson B, Man KC, Vorperian V, Hummel JD, Hasse C, Strickberger SA, Calkins H, Langberg JJ, Morady F.
    J Am Coll Cardiol; 1993 Nov 15; 22(6):1723-9. PubMed ID: 8227846
    [Abstract] [Full Text] [Related]

  • 12. Amiodarone therapy for sustained ventricular tachycardia after myocardial infarction: long-term follow-up, risk assessment and predictive value of programmed ventricular stimulation.
    Maury P, Zimmermann M, Metzger J, Reynard C, Dorsaz P, Adamec R.
    Int J Cardiol; 2000 Nov 15; 76(2-3):199-210. PubMed ID: 11104875
    [Abstract] [Full Text] [Related]

  • 13. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ, MADIT II Study Investigators.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):98-107. PubMed ID: 16386671
    [Abstract] [Full Text] [Related]

  • 14. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD.
    J Cardiovasc Electrophysiol; 2012 Mar 03; 23(3):296-301. PubMed ID: 21955243
    [Abstract] [Full Text] [Related]

  • 15. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
    Tsuchiya M, Kasanuki H, Ohnishi S, Hosoda S.
    J Cardiol; 1996 Nov 03; 28(5):267-76. PubMed ID: 8953400
    [Abstract] [Full Text] [Related]

  • 16. Idiopathic ventricular fibrillation: clinical, electrophysiologic characteristics and long-term outcomes.
    Tsai CF, Chen SA, Tai CT, Chiang CE, Ding YA, Chang MS.
    Int J Cardiol; 1998 Mar 13; 64(1):47-55. PubMed ID: 9579816
    [Abstract] [Full Text] [Related]

  • 17. A prospective study of the efficacy and safety of adjuvant metoprolol and xamoterol in combination with amiodarone for resistant ventricular tachycardia associated with impaired left ventricular function.
    Bashir Y, Paul VE, Griffith MJ, Sneddon JF, Farrell TG, Ward DE, Camm AJ.
    Am Heart J; 1992 Nov 13; 124(5):1233-40. PubMed ID: 1442491
    [Abstract] [Full Text] [Related]

  • 18. Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia.
    Man KC, Williamson BD, Niebauer M, Daoud E, Bakr O, Strickberger SA, Hummel JD, Kou W, Morady F.
    Am J Cardiol; 1994 Dec 01; 74(11):1119-23. PubMed ID: 7977070
    [Abstract] [Full Text] [Related]

  • 19. Long-term reproducibility of ventricular tachycardia induction in patients with implantable cardioverter/defibrillators. Serial noninvasive studies.
    Gillis AM, Sheldon RS, Wyse DG, Leitch JW, Yee R, Klein GJ, Duff HJ, Mitchell LB.
    Circulation; 1995 May 15; 91(10):2605-13. PubMed ID: 7743623
    [Abstract] [Full Text] [Related]

  • 20. Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: inducibility and prognostic value in 102 patients.
    Chen X, Shenasa M, Borggrefe M, Block M, Hindricks G, Martinez-Rubio A, Haverkamp W, Willems S, Böcker D, Mäkijärvi M.
    Eur Heart J; 1994 Jan 15; 15(1):76-82. PubMed ID: 8174587
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.